Safety assessment of treatment with bevacizumab in metastatic colorectal cancer: an observational study.
Phase of Trial: Phase IV
Latest Information Update: 28 Jun 2014
At a glance
- Drugs Bevacizumab (Primary) ; Antineoplastics
- Indications Colorectal cancer
- Focus Adverse reactions
- 04 Jan 2012 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 16 Nov 2010 New trial record